A highly sensitive SERS‐based platform measures PD‐L1 expression on EpCAM+ circulating EVs from cancer patients undergoing immunotherapy. Monitoring dynamic changes after treatment reveals that reduced EpCAM+ EV PD‐L1 levels associate with improved long‐term clinical outcomes, establishing a non‐invasive approach for tracking immune checkpoint ...
Byeonggeol Mun +15 more
wiley +1 more source
HMCN1 as a conserved biomarker of epithelial-mesenchymal transition: a cross-cancer analysis. [PDF]
Leng Y, Liu Y, Zhi L.
europepmc +1 more source
Umbilical cord stem cell‐derived exosomes encapsulated in an immunomodulatory bioadhesive hydrogel spray enable localized therapy, sustained vesicle delivery, macrophage polarization, suppress systemic inflammation, and mitigate glucose and insulin homeostasis impairments in MAFLD.
Triya Saha +4 more
wiley +1 more source
Deacetylforskolin ameliorates bleomycin-induced pulmonary fibrosis by suppressing inflammation and TGF-β1-induced epithelial-mesenchymal transition. [PDF]
Zhong Y +9 more
europepmc +1 more source
Erratum: Notch signaling induces epithelial-mesenchymal transition to promote invasion and metastasis in adenoid cystic carcinoma. [PDF]
Zhao ZL +10 more
europepmc +1 more source
Detection of circulating tumor cells in cholangiocarcinoma via epithelial-mesenchymal transition markers and their application. [PDF]
Liu Y +6 more
europepmc +1 more source
GLIS3 drives epithelial-mesenchymal transition and cancer stem-like traits in stomach adenocarcinoma via TGFBR3-Hedgehog signaling. [PDF]
Xiao Q, Deng H, Li J, Zheng Y, Zhang Y.
europepmc +1 more source
Epithelial-mesenchymal transition and sunitinib resistance in renal cell carcinoma: mechanisms and therapeutic strategies. [PDF]
Zhang M +9 more
europepmc +1 more source
miR-1229-3p promotes epithelial-mesenchymal transition and metastasis of cervical cancer cells by targeting FBXL5. [PDF]
Lan D, Sun X, Yao L, Cao B.
europepmc +1 more source

